ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,736Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 663

$844K Total Retail Price of All Prescriptions

Rank: 15 out of 663

700 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 700 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

12% of this provider’s 700 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,046 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
LEVOTHYROXINE SODIUM 711 627 1 3
SIMVASTATIN 626 592 2 1
LISINOPRIL 459 432 3 2
FUROSEMIDE 438 399 4 7
WARFARIN SODIUM 419 385 5 8
HYDROCODONE-ACETAMINOPHEN 295 204 S3 6 6
OMEPRAZOLE 294 254 7 4
METOPROLOL TARTRATE 262 240 8 11
GABAPENTIN 254 186 9 20
AMLODIPINE BESYLATE 241 231 10 5
METFORMIN HCL 227 196 11 9
HYDROCHLOROTHIAZIDE 217 216 12 12
POTASSIUM CHLORIDE 216 203 13 23
CITALOPRAM HBR 210 154 14 18
TRAMADOL HCL 191 149 15 17
ZOLPIDEM TARTRATE 174 139 16 16
LANTUS 164 159 17 48
CARVEDILOL 159 155 18 47
PREDNISONE 149 129 19 39
GLIMEPIRIDE 143 134 20 84
LOSARTAN POTASSIUM 141 130 21 14
METOPROLOL SUCCINATE 129 129 22 25
DONEPEZIL HCL 127 101 23 40
NAMENDA 118 106 24 57
MIRTAZAPINE 117 117 25 52
ATORVASTATIN CALCIUM 105 98 26 13
CYMBALTA 104 76 27 54
ALLOPURINOL 102 84 28 28
OXYCODONE-ACETAMINOPHEN 100 87 S2 29 26
ATENOLOL 98 87 30 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 88 31 22
TAMSULOSIN HCL 96 93 32 24
SPIRONOLACTONE 88 75 33 58
RISPERIDONE 87 86 34 87
CRESTOR 86 86 35 37
SYNTHROID 86 82 35 46
CEPHALEXIN 79 72 37 119
CIPROFLOXACIN HCL 79 72 37 74
SERTRALINE HCL 78 60 39 35
LOVASTATIN 78 74 39 30
ALENDRONATE SODIUM 77 70 41 15
AZITHROMYCIN 77 72 41 64
INSULIN SYRINGE 74 51 43 55
OLANZAPINE 71 58 44 88
CELEBREX 71 47 44 85
CLOPIDOGREL 65 58 46 65
PRAVASTATIN SODIUM 65 60 46 21
DIOVAN 64 61 48 59
FAMOTIDINE 64 64 48 76
PANTOPRAZOLE SODIUM 63 36 50 45
MORPHINE SULFATE ER 63 37 S2 50 51
PAROXETINE HCL 63 51 50 68
NOVOLOG 63 56 50 143
DIVALPROEX SODIUM 62 59 54 81
MELOXICAM 60 57 55 61
NEXIUM 59 50 56 43
TRAZODONE HCL 57 41 57 34
CYCLOBENZAPRINE HCL 55 37 R 58 71
TRIAMTERENE-HCTZ 55 53 58 42
KLOR-CON M10 55 52 58 139
RAMIPRIL 54 41 61 132
LEVOXYL 54 52 61 133
GEMFIBROZIL 52 49 63 109
KLOR-CON M20 50 49 64 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.